EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Biomimetic nanomaterials in myocardial infarction treatment: Harnessing bionic strategies for advanced therapeutics

Tingting Yu, Qiaxin Xu, Xu Chen, Xiujiao Deng, Nenghua Chen, Man Teng Kou, Yanyu Huang, Jun Guo, Zeyu Xiao, Jinghao Wang

Materials Today Bio · 2024-04 · 25 · 100957

DOI: 10.1016/j.mtbio.2024.100957 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2024-04. Verfasst von Tingting Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI) and its associated poor prognosis pose significant risks to human health. Nanomaterials hold great potential for the treatment of MI due to their targeted and controlled release properties, particularly biomimetic nanomaterials. The utilization of biomimetic strategies based on extracellular vesicles (EVs) and cell membranes will serve as the guiding principle for the development of nanomaterial therapy in the future. In this review, we present an overview of research progress on various exosomes derived from mesenchymal stem cells, cardiomyocytes, or induced pluripotent stem cells in the context of myocardial infarction (MI) therapy. These exosomes, utilized as cell-free therapies, have demonstrated the ability to enhance the efficacy of reducing the size of the infarcted area and preventing ischaemic reperfusion through mechanisms such as oxidative stress reduction, polarization modulation, fibrosis inhibition, and angiogenesis promotion. Moreover, EVs can exert cardioprotective effects by encapsulating therapeutic agents and can be engineered to specifically target the infarcted myocardium. Furthermore, we discuss the use of cell membranes derived from erythrocytes, stem cells, immune cells and platelets to encapsulate nanomaterials. This approach allows the nanomaterials to camouflage themselves as endogenous substances targeting the region affected by MI, thereby minimizing toxicity and improving biocompatibility. In conclusion, biomimetic nano-delivery systems hold promise as a potentially beneficial technology for MI treatment. This review serves as a valuable reference for the application of biomimetic nanomaterials in MI therapy and aims to expedite the translation of NPs-based MI therapeutic strategies into practical clinical applications.

Schlagwörter

Stichwörter der Autor:innen

Biomimetic nanomaterialsBionanomaterialsCell membranesExosomesExtracellular vehiclesMyocardial infarction

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
  • The Guangzhou Key Laboratory of Basic and Translational Research on Chronic Diseases, Jinan University, Guangzhou, 510630, China.
  • Department of Clinical Pharmacy, Daqing Oilfield General Hospital, Daqing, 163000, China.
  • Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, 95817, USA.
  • Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
  • The Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation, Jinan University, Guangzhou, 510630, China.

Zitieren

APA

Yu, T., Xu, Q., Chen, X., Deng, X., Chen, N., Kou, M. T., Huang, Y., Guo, J., Xiao, Z., & Wang, J. (2024). Biomimetic nanomaterials in myocardial infarction treatment: Harnessing bionic strategies for advanced therapeutics. Materials Today Bio, 25, 100957. https://doi.org/10.1016/j.mtbio.2024.100957

Vancouver

Yu T, Xu Q, Chen X, Deng X, Chen N, Kou MT, et al. Biomimetic nanomaterials in myocardial infarction treatment: Harnessing bionic strategies for advanced therapeutics. Materials Today Bio. 2024;25:100957. doi:10.1016/j.mtbio.2024.100957

BibTeX
@article{Yu2024,
  author = {Yu, Tingting and Xu, Qiaxin and Chen, Xu and Deng, Xiujiao and Chen, Nenghua and Kou, Man Teng and Huang, Yanyu and Guo, Jun and Xiao, Zeyu and Wang, Jinghao},
  title = {Biomimetic nanomaterials in myocardial infarction treatment: Harnessing bionic strategies for advanced therapeutics},
  journal = {Materials Today Bio},
  year = {2024},
  volume = {25},
  pages = {100957},
  doi = {10.1016/j.mtbio.2024.100957}
}
Kostenlos starten →